1
|
Sharma P, LaRosa C, Antwi J, Govindarajan R, Werbovetz KA. Imidazoles as Potential Anticancer Agents: An Update on Recent Studies. Molecules 2021; 26:molecules26144213. [PMID: 34299488 PMCID: PMC8307698 DOI: 10.3390/molecules26144213] [Citation(s) in RCA: 51] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Revised: 06/30/2021] [Accepted: 07/05/2021] [Indexed: 12/14/2022] Open
Abstract
Nitrogen-containing heterocyclic rings are common structural components of marketed drugs. Among these heterocycles, imidazole/fused imidazole rings are present in a wide range of bioactive compounds. The unique properties of such structures, including high polarity and the ability to participate in hydrogen bonding and coordination chemistry, allow them to interact with a wide range of biomolecules, and imidazole-/fused imidazole-containing compounds are reported to have a broad spectrum of biological activities. This review summarizes recent reports of imidazole/fused imidazole derivatives as anticancer agents appearing in the peer-reviewed literature from 2018 through 2020. Such molecules have been shown to modulate various targets, including microtubules, tyrosine and serine-threonine kinases, histone deacetylases, p53-Murine Double Minute 2 (MDM2) protein, poly (ADP-ribose) polymerase (PARP), G-quadraplexes, and other targets. Imidazole-containing compounds that display anticancer activity by unknown/undefined mechanisms are also described, as well as key features of structure-activity relationships. This review is intended to provide an overview of recent advances in imidazole-based anticancer drug discovery and development, as well as inspire the design and synthesis of new anticancer molecules.
Collapse
Affiliation(s)
- Pankaj Sharma
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA; (P.S.); (C.L.)
| | - Chris LaRosa
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA; (P.S.); (C.L.)
| | - Janet Antwi
- Division of Mathematics, Computer & Natural Sciences Division, Ohio Dominican University, Columbus, OH 43219, USA;
| | - Rajgopal Govindarajan
- Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA;
| | - Karl A. Werbovetz
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA; (P.S.); (C.L.)
- Correspondence:
| |
Collapse
|
2
|
Design, synthesis and molecular docking study of new purine derivatives as Aurora kinase inhibitors. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2020.129843] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
3
|
Froux L, Elbahnsi A, Boucherle B, Billet A, Baatallah N, Hoffmann B, Alliot J, Zelli R, Zeinyeh W, Haudecoeur R, Chevalier B, Fortuné A, Mirval S, Simard C, Lehn P, Mornon JP, Hinzpeter A, Becq F, Callebaut I, Décout JL. Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activity. Eur J Med Chem 2020; 190:112116. [DOI: 10.1016/j.ejmech.2020.112116] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2019] [Revised: 01/24/2020] [Accepted: 02/03/2020] [Indexed: 02/06/2023]
|
4
|
Chotard F, Lapenta R, Bolley A, Trommenschlager A, Balan C, Bayardon J, Malacea-Kabbara R, Bonnin Q, Bodio E, Cattey H, Richard P, Milione S, Grassi A, Dagorne S, Le Gendre P. Phenoxyamidine Zn and Al Complexes: Synthesis, Characterization, and Use in the Ring-Opening Polymerization of Lactide. Organometallics 2019. [DOI: 10.1021/acs.organomet.9b00501] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Florian Chotard
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Rosita Lapenta
- Institut de Chimie de Strasbourg (UMR-CNRS 7177), Université de Strasbourg, F-67081 Strasbourg cedex, France
- Dipartimento di Chimica e Biologia, Università degli Studi di Salerno, via Giovanni Paolo II, 132-84084 Fisciano (SA), Italy
| | - Anaëlle Bolley
- Institut de Chimie de Strasbourg (UMR-CNRS 7177), Université de Strasbourg, F-67081 Strasbourg cedex, France
| | - Audrey Trommenschlager
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Cédric Balan
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Jérôme Bayardon
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Raluca Malacea-Kabbara
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Quentin Bonnin
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Ewen Bodio
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Hélène Cattey
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Philippe Richard
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| | - Stefano Milione
- Dipartimento di Chimica e Biologia, Università degli Studi di Salerno, via Giovanni Paolo II, 132-84084 Fisciano (SA), Italy
| | - Alfonso Grassi
- Dipartimento di Chimica e Biologia, Università degli Studi di Salerno, via Giovanni Paolo II, 132-84084 Fisciano (SA), Italy
| | - Samuel Dagorne
- Institut de Chimie de Strasbourg (UMR-CNRS 7177), Université de Strasbourg, F-67081 Strasbourg cedex, France
| | - Pierre Le Gendre
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB, UMR-CNRS 6302), Université Bourgogne Franche-Comté 25000 Besançon, France
| |
Collapse
|
5
|
Zhu H, Qu ZW, Grimme S. Borane-Catalyzed Hydrogenation of Tertiary Amides Activated by Oxalyl Chloride: DFT Mechanistic Insights. European J Org Chem 2019. [DOI: 10.1002/ejoc.201900827] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Hui Zhu
- Mulliken Center for Theoretical Chemistry; University of Bonn; Beringstr. 4 53115 Bonn Germany
| | - Zheng-Wang Qu
- Mulliken Center for Theoretical Chemistry; University of Bonn; Beringstr. 4 53115 Bonn Germany
| | - Stefan Grimme
- Mulliken Center for Theoretical Chemistry; University of Bonn; Beringstr. 4 53115 Bonn Germany
| |
Collapse
|
6
|
Tosh DK, Rao H, Bitant A, Salmaso V, Mannes P, Lieberman DI, Vaughan KL, Mattison JA, Rothwell AC, Auchampach JA, Ciancetta A, Liu N, Cui Z, Gao ZG, Reitman ML, Gavrilova O, Jacobson KA. Design and in Vivo Characterization of A 1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series. J Med Chem 2019; 62:1502-1522. [PMID: 30605331 PMCID: PMC6467784 DOI: 10.1021/acs.jmedchem.8b01662] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
(N)-Methanocarba ([3.1.0]bicyclohexyl) adenosines and corresponding ribosides were synthesized to identify novel A1 adenosine receptor (A1AR) agonists for CNS or peripheral applications. Human and mouse AR binding was determined to assess the constrained ring system's A1AR compatibility. N6-Dicyclobutylmethyl ribose agonist (9, MRS7469, >2000-fold selective for A1AR) and known truncated N6-dicyclopropylmethyl methanocarba 7 (MRS5474) were drug-like. The pure diastereoisomer of known riboside 4 displayed high hA1AR selectivity. Methanocarba modification reduced A1AR selectivity of N6-dicyclopropylmethyl and endo-norbornyladenosines but increased ribavirin selectivity. Most analogues tested (ip) were inactive or weak in inducing mouse hypothermia, despite mA1AR full agonism and variable mA3AR efficacy, but strong hypothermia by 9 depended on A1AR, which reflects CNS activity (determined using A1AR or A3AR null mice). Conserved hA1AR interactions were preserved in modeling of 9 and methanocarba equivalent 24 (∼400-fold A1AR-selective). Thus, we identified, and characterized in vivo, ribose and methanocarba nucleosides, including with A1AR-enhancing N6-dicyclobutylmethyl-adenine and 1,2,4-triazole-3-carboxamide (40, MRS7451) nucleobases.
Collapse
Affiliation(s)
- Dilip K. Tosh
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Harsha Rao
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Amelia Bitant
- Department of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, USA 53226
| | - Veronica Salmaso
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Philip Mannes
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - David I. Lieberman
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Kelli L. Vaughan
- SoBran BioSciences, SoBran, Inc., 4000 Blackburn Lane, Burtonsville, MD, USA 20866
- Translational Gerontology Branch, National Institute on Aging Intramural Research Program, 16701 Elmer School Rd., Bldg. 103, Dickerson, MD, USA 20842
| | - Julie A. Mattison
- Translational Gerontology Branch, National Institute on Aging Intramural Research Program, 16701 Elmer School Rd., Bldg. 103, Dickerson, MD, USA 20842
| | - Amy C. Rothwell
- Department of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, USA 53226
| | - John A. Auchampach
- Department of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, USA 53226
| | - Antonella Ciancetta
- Queen’s University Belfast, School of Pharmacy, 96 Lisburn Rd, Belfast BT9 7BL, UK
| | - Naili Liu
- Mouse Metabolism Core, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Zhenzhong Cui
- Mouse Metabolism Core, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Zhan-Guo Gao
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Marc L. Reitman
- Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Oksana Gavrilova
- Mouse Metabolism Core, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| | - Kenneth A. Jacobson
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MA, USA 20892
| |
Collapse
|
7
|
Sitte NA, Bursch M, Grimme S, Paradies J. Frustrated Lewis Pair Catalyzed Hydrogenation of Amides: Halides as Active Lewis Base in the Metal-Free Hydrogen Activation. J Am Chem Soc 2018; 141:159-162. [DOI: 10.1021/jacs.8b12997] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Nikolai A. Sitte
- University of Paderborn, Department of Chemistry, Warburger Strasse 100, D-33098 Paderborn, Germany
| | - Markus Bursch
- University of Bonn, Mulliken Center for Theoretical Chemistry, Beringstr. 4, D-53115 Bonn, Germany
| | - Stefan Grimme
- University of Bonn, Mulliken Center for Theoretical Chemistry, Beringstr. 4, D-53115 Bonn, Germany
| | - Jan Paradies
- University of Paderborn, Department of Chemistry, Warburger Strasse 100, D-33098 Paderborn, Germany
| |
Collapse
|
8
|
Zelli R, Zeinyeh W, Décout JL. 6-Chloropurine Ribonucleosides from Chloropyrimidines: One-Pot Synthesis. ACTA ACUST UNITED AC 2018; 74:e57. [PMID: 30102466 DOI: 10.1002/cpnc.57] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
A one-pot glycosylation and cyclization procedure is described for the synthesis of 6-chloropurine ribonucleosides from chloropyrimidines. From such a procedure and modification of the obtained chloropurine ribonucleosides, many drug candidates or molecular tools for biological study designed from their similarity to naturally occurring nucleosides could be obtained. The synthesis begins by preparation of several amidinoaminochloropyrimidines as precursors for the one-pot procedure. Then, by adding trimethylsilyl trifluoromethanesulfonate (TMSOTf) to a mixture of a pyrimidine and 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribose, different 6-chloropurine ribonucleosides are obtained. This methodology allows the straightforward introduction of an alkyl substituent at position 8 of purine ribonucleosides, which then can be functionalized at positions 2 and 6. © 2018 by John Wiley & Sons, Inc.
Collapse
Affiliation(s)
- Renaud Zelli
- Université Grenoble Alpes, CNRS, DPM, Grenoble, France
| | - Waël Zeinyeh
- Université Grenoble Alpes, CNRS, DPM, Grenoble, France.,Université Grenoble Alpes, CNRS, CEA, BIG-LCBM, Grenoble, France.,ISPB-Faculté de Pharmacie, Université de Lyon 1, Lyon, France
| | | |
Collapse
|